Labman Leads International Project To Develop Ai-powered Bioreactor Platform For Next-generation Biologics

Labman is proud to beryllium progressive successful a groundbreaking Canada-UK collaboration to revolutionize biopharmaceutical manufacturing utilizing cutting-edge automation, AI, and real-time process control.

Image Credit: Labman

The AI-optimized BALANCE (Bioreactor Automation for Learning and Adaptive Networked Control of Experiments) level will bring together nan mixed expertise of CPI (UK), Basetwo (Canada), Nicoya (Canada), and Labman Automation (UK), supported by a $2 cardinal assistance from Innovate UK and nan National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).

At nan halfway of this 20-month collaboration is nan creation of a demonstrator level that integrates smart bioreactor technologies, real-time sensing, AI-driven optimization, and precocious modular automation. Labman will creation and build a afloat automated modular sampling system, enabling molecular study of compartment cultures pinch minimal manual intervention. This will seamlessly merge pinch Nicoya's Alto SPR biosensor to present instant feedback connected output and quality, providing adaptive power complete nan process successful real-time.

The BALANCE strategy is underpinned by Basetwo's integer copy technology, a instrumentality learning level that interprets real-time information from biosensors and bioreactors to make intelligent decisions astir process conditions. This closed-loop power strategy enables continuous optimization, predicting outcomes and reducing nan request for costly lab-based testing.

This is nan adjacent measurement for biologics and supplier manufacturing, integrating Industry 4.0 approaches for bioprocessing. By combining precocious sensing, AI and automation, we purpose to accelerate process development, amended consistency, and create smarter, much businesslike biomanufacturing workflows."

Tom Smith, Head of bioprocess automation, Labman

By streamlining upstream bioprocessing and enabling move control, this task intends to amended yield, scalability, and velocity to marketplace for biologic therapeutics. CPI will lead strategy validation, ensuring nan level is not only technically robust, but scalable and commercially viable.

This collaboration marks a awesome measurement guardant successful nan digitization of biologics manufacturing. For Labman, it's different breathtaking opportunity to show really intelligent, elastic automation tin toggle shape analyzable technological processes, and we're thrilled to beryllium astatine nan forefront.